Literature DB >> 30726518

Design Considerations in the Development of App-Based Oral Anticancer Medication Management Systems: a Qualitative Evaluation of Pharmacists' and Patients' Perspectives.

Eskinder Eshetu Ali1, Sharlene Si Ling Chan1, Huan Yu Poh2, Yosua Amadeus Susanto2, Thendral Suganya1, Jo Lene Leow3, Chee Khiang Pang2,4, Lita Chew1,3, Kevin Yi-Lwern Yap5.   

Abstract

Smartphone apps can potentially help in enhancing oral anticancer medication (OAM) adherence. Patient adoption and efficacy of such apps depends on inclusion of user-centred and evidence-based features. The objective of this study was to identify important design considerations from the perspectives of patients taking OAMs, caregivers and oncology pharmacists. The study employed a qualitative study design. Data were collected using in-depth interviews with patients (n = 15), caregivers (n = 3) and pharmacists (n = 16). Interviews were audio-recorded, transcribed verbatim and inductive thematic analysis approach was used in data analysis. Monitoring medication-related problems, medication information, replacement of or integration with current systems and accessibility of app content on devices other than smartphones were the key themes identified in the analysis. Flexible input methods for monitored data, glanceability of monitored reports/information, near real-time adherence enhancing and symptom management interventions and customisable reminder options were design considerations identified under the monitoring medication-related problems theme. Participants suggested the provision of focused and easily understandable medication information with a potential for personalisation. Integration of app-based adherence systems with patients' electronic medical records with added mechanisms for alerts in the dispensing system was also suggested as a key design requirement to improve quality of patient care and facilitate adoption by clinicians. Finally, smartphones were the most favoured platform with optional accessibility of app content on other devices. In conclusion, important design considerations were identified through a user-centred design approach. The findings will help developers and clinicians in the design of new app-based systems and evaluation of existing ones.

Entities:  

Keywords:  Adherence apps; Design requirement; Medication adherence; Oral anticancer medication; User-centred design

Mesh:

Substances:

Year:  2019        PMID: 30726518     DOI: 10.1007/s10916-019-1168-x

Source DB:  PubMed          Journal:  J Med Syst        ISSN: 0148-5598            Impact factor:   4.460


  52 in total

Review 1.  Patient adherence to oral anticancer drugs: an emerging issue in modern oncology.

Authors:  V Foulon; P Schöffski; P Wolter
Journal:  Acta Clin Belg       Date:  2011 Mar-Apr       Impact factor: 1.264

2.  A development and evaluation process for mHealth interventions: examples from New Zealand.

Authors:  Robyn Whittaker; Sally Merry; Enid Dorey; Ralph Maddison
Journal:  J Health Commun       Date:  2012

Review 3.  Adherence enhancing interventions for oral anticancer agents: a systematic review.

Authors:  Tim Mathes; Sunya-Lee Antoine; Dawid Pieper; Michaela Eikermann
Journal:  Cancer Treat Rev       Date:  2013-08-01       Impact factor: 12.111

4.  mHealth consumer apps: the case for user-centered design.

Authors:  Tara McCurdie; Svetlena Taneva; Mark Casselman; Melanie Yeung; Cassie McDaniel; Wayne Ho; Joseph Cafazzo
Journal:  Biomed Instrum Technol       Date:  2012

5.  Feasibility pilot on medication adherence and knowledge in ambulatory patients with gastrointestinal cancer.

Authors:  Robin M Sommers; Kathleen Miller; Donna L Berry
Journal:  Oncol Nurs Forum       Date:  2012-07       Impact factor: 2.172

Review 6.  Determinants and associated factors influencing medication adherence and persistence to oral anticancer drugs: a systematic review.

Authors:  M Verbrugghe; S Verhaeghe; K Lauwaert; D Beeckman; A Van Hecke
Journal:  Cancer Treat Rev       Date:  2013-02-19       Impact factor: 12.111

7.  Treatment monitoring program for implementation of adherence to second-line erlotinib for advanced non-small-cell lung cancer.

Authors:  Vittorio Gebbia; Massimo Bellavia; Giuseppe Luigi Banna; Paolo Russo; Francesco Ferraù; Paolo Tralongo; Nicolò Borsellino
Journal:  Clin Lung Cancer       Date:  2013-01-10       Impact factor: 4.785

8.  The Patient's Anastrozole Compliance to Therapy (PACT) Program: a randomized, in-practice study on the impact of a standardized information program on persistence and compliance to adjuvant endocrine therapy in postmenopausal women with early breast cancer.

Authors:  P Hadji; M Blettner; N Harbeck; C Jackisch; H-J Lück; C Windemuth-Kieselbach; S Zaun; R Kreienberg
Journal:  Ann Oncol       Date:  2013-02-01       Impact factor: 32.976

9.  Medication nonadherence: a diagnosable and treatable medical condition.

Authors:  Zachary A Marcum; Mary Ann Sevick; Steven M Handler
Journal:  JAMA       Date:  2013-05-22       Impact factor: 56.272

10.  Text message intervention designs to promote adherence to antiretroviral therapy (ART): a meta-analysis of randomized controlled trials.

Authors:  David J Finitsis; Jennifer A Pellowski; Blair T Johnson
Journal:  PLoS One       Date:  2014-02-05       Impact factor: 3.240

View more
  4 in total

1.  Development of a Mobile-Based Self-care Application for Patients with Breast Cancer-Related Lymphedema in Iran.

Authors:  Maryam Ahmadi; Seyedeh Nafiseh Shahrokhi; Morteza Khavaninzadeh; Jahanpour Alipour
Journal:  Appl Clin Inform       Date:  2022-10-05       Impact factor: 2.762

Review 2.  Self-care behaviors in patients with cancer treated with oral anticancer agents: a systematic review.

Authors:  Marco Di Nitto; Fabio Sollazzo; Valentina Biagioli; Gianluca Pucciarelli; Francesco Torino; Rosaria Alvaro; Ercole Vellone
Journal:  Support Care Cancer       Date:  2022-05-31       Impact factor: 3.359

Review 3.  A Concept Analysis of Oral Anticancer Agent Self-management.

Authors:  Madilyn Mason; Marcelline R Harris; Joseph A Greer; Yun Jiang
Journal:  Cancer Nurs       Date:  2022 Mar-Apr 01       Impact factor: 2.592

4.  Impact of mobile applications on adherence to cancer treatment: a systematic review and meta-analysis protocol.

Authors:  Kleyton Santos Medeiros; Janice França Queiroz; Michelly Nóbrega Monteiro; Weruska Alcoforado Costa; Ricardo Ney Cobucci; Beatriz Stransky; Ana Katherine Gonçalves
Journal:  BMJ Open       Date:  2019-11-07       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.